Health ❯Infectious Diseases

Respiratory Syncytial Virus (RSV)

Prevention Risk Factors Disease Impact Treatment Vaccination Antibody Drugs Severity Increase in Respiratory Diseases Nirsevimab RSV Vaccines Lower Respiratory Tract Disease

Investigation Underway into RSV Vaccines and Guillain-Barré Syndrome Link

First RSV Vaccine Approved for Older Adults Amid Rising Infections

CDC Releases Additional Doses of RSV Treatment Amid Rising Infections

RSV Shot Beyfortus Faces Shortage Amid Increasing Demand; CDC Advises Priority for High-Risk Infants

Rising RSV cases in Southeast US prompt CDC warning of early start to RSV season nationwide

CDC panel unanimously recommends new RSV antibody treatment for infants and high-risk toddlers

FDA Approves First Long-Acting Antibody Shot to Prevent RSV in Infants and Toddlers